Kim LH, Kang SM, Whang J, Kwon KW, et al. Novel Antibacterial Activity of Febuxostat, an FDA-Approved Antigout Drug against Mycobacterium tuberculosis Infection. Antimicrob Agents Chemother 2022 Aug 30:e0076222. doi: 10.1128/aac.00762.
PMID: 36040172